Antimicrobial susceptibilities of Propionibacterium acnes isolated from patients with acne vulgaris

Microbiology and Immunology

Volumn 52, Issue 12, 2008, Pages 621-624

  Ishida, Natsumi ^a   Nakaminami, Hidemasa ^a   Noguchi, Norihisa ^a   Kurokawa, Ichiro ^b   Nishijima, Setsuko ^c   Sasatsu, Masanori ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b Nishijima Skin Clinic   (Japan)

^c MIE UNIVERSITY   (Japan)

Author keywords

23S rRNA; Acne vulgaris; Macrolides; P. acnes

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN; RNA 23S; ANTIINFECTIVE AGENT; BACTERIAL DNA; BACTERIAL PROTEIN; PEPTIDYLTRANSFERASE; RIBOSOME DNA;

ACNE VULGARIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; ERYTHROMYCIN RIBOSOME METHYLASE GENE; GENE MUTATION; HUMAN; NUCLEOTIDE SEQUENCE; PROPIONIBACTERIUM ACNES; SEQUENCE ANALYSIS; DRUG EFFECT; GENETICS; GRAM POSITIVE INFECTION; ISOLATION AND PURIFICATION; JAPAN; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MUTATION;

PROPIONIBACTERIUM ACNES;

ACNE VULGARIS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DNA, BACTERIAL; DNA, RIBOSOMAL; DRUG RESISTANCE, BACTERIAL; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; JAPAN; MICROBIAL SENSITIVITY TESTS; MUTATION; PEPTIDYL TRANSFERASES; PROPIONIBACTERIUM ACNES; RNA, RIBOSOMAL, 23S;

EID: 59449105622     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2008.00081.x     Document Type: Article

References (17)

1. Haider A., Shaw J.C. (2004) Treatment of acne vulgaris. JAMA 292: 726-35.
2. Oprica C., Lofmark S., Lund B., Edlund C., Emtestam L., Nord C.E. (2005) Genetic basis of resistance in Propionibacterium acnes strains isolated from diverse types of infection in different European countries. Anaerobe 11: 137-43.
3. Ross J.I., Eady E.A., Cove J.H., Jones C.E., Ratyal A.H., Miller Y.W., Vyakrnam S., Cunliffe W.J. (1997) Clinical resistance to erythromycin and clindamycin in cutaneous propionibacteria isolated from acne patients is associated with mutations in 23S rRNA. Antimicrob Agents Chemother 41: 1162-5.
4. Nishijima S., Kurokawa I., Kawabata S. (1996) Sensitivity of Propionibacterium acnes isolated from acne patients: comparative study of antimicrobial agents. J Int Med Res 24: 473-7.
5. Kurokawa I., Nishijima S., Kawabata S. (1999) Antimicrobial susceptibility of Propionibacterium acnes isolated from acne vulgaris. Eur J Dermatol 9: 25-8.
6. Jain A., Sangal L., Basal E., Kaushal G.P., Agarwal S.K. (2002) Anti-inflammatory effects of erythromycin and tetracycline on Propionibacterium acnes induced production of chemotactic factors and reactive oxygen species by human neutrophils. Dermatol Online J 8: 2.
7. Ross J.I., Snelling A.M., Eady E.A., Cove J.H., Cunliffe W.J., Leyden J.J., Collignon P., Dreno B., Reynaud A., Fluhr J., Oshima S. (2001) Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia. Br J Dermatol 144: 339-46.
8. Eady E.A., Gloor M., Leyden J.J. (2003) Propionibacterium acnes resistance: a worldwide problem. Dermatology 206: 54-6.
9. Heller S., Kellenberger L., Shapiro S. (2007) Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic. Antimicrob Agents Chemother 51: 1956-61.
10. Ross J.I., Snelling A.M., Carnegie E., Coates P., Cunliffe W.J., Bettoli V., Tosti G., Katsambas A., Galvan Perez Del Pulgar J.I., Rollman O., Torok L., Eady E.A., Cove J.H. (2003) Antibiotic-resistant acne: lessons from Europe. Br J Dermatol 148: 467-78.
11. Ross J.I., Eady E.A., Carnegie E., Cove J.H. (2002) Detection of transposon Tn5432-mediated macrolide-lincosamide-streptogramin B (MLSB) resistance in cutaneous propionibacteria from six European cities. J Antimicrob Chemother 49: 165-8.
12. CLSI. (2001) Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard-Fifth Edition M11-A5.
13. Meier A., Kirschner P., Springer B., Steingrube V.A., Brown B.A., Wallace R.J. Jr., Bottger E.C. (1994) Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare. Antimicrob Agents Chemother 38: 381-4.
14. Nakaminami H., Noguchi N., Nishijima S., Kurokawa I., Sasatsu M. (2008) Characterization of the plasmid pTZ2162 encoding multidrug efflux gene qacB from Staphylococcus aureus. Plasmid 60: 108-17.
15. Weisblum B. (1995) Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother 39: 577-85.
16. Ettayebi M., Prasad S.M., Morgan E.A. (1985) Chloramphenicol-erythromycin resistance mutations in a 23S rRNA gene of Escherichia coli. J Bacteriol 162: 551-7.
17. Vannuffel P., Di Giambattista M., Morgan E.A., Cocito C. (1992) Identification of a single base change in ribosomal RNA leading to erythromycin resistance. J Biol Chem 267: 8377-82.